[February 05, 2016]

Cancer Pain Pipeline Review, H2 2015 - Research and Markets

Research and Markets (http://www.researchandmarkets.com/research/jrq399/cancer_pain) has announced the addition of the "Cancer Pain - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Cancer Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cancer Pain and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products.

Key Topics Covered:

1. Introduction
3. Therapeutics Development
4. Pipeline Products for Cancer Pain - Overview
5. Pipeline Products for Cancer Pain - Comparative Analysis
6. Cancer Pain - Therapeutics under Development by Companies
7. Cancer Pain - Therapeutics under Investigation by Universities/Institutes
8. Cancer Pain - Pipeline Products Glance
9. Late Stage Products
10. Clinical Stage Products
11. Early Stage Products
12. Cancer Pain - Products under Development by Companies
13. Cancer Pain - Products under Investigation by Universities/Institutes
14. Cancer Pain - Companies Involved in Therapeutics Development

• Amgen Inc.
• Amorsa Therapeutics Inc.
• AngioChem Inc.
• Aphios Corporation
• AstraZeneca Plc
• BCN (News - Alert) Peptides, S.A.
• Benitec Biopharma Limited
• BioDelivery Sciences International, Inc.
• ChironWells GmbH
• Daiichi Sankyo Company, Limited
• Fujimoto Pharmaceutical Corporation
• Grunenthal GmbH
• GW Pharmaceuticals Plc
• Hisamitsu Pharmaceutical Co., Inc.
• Immupharma Plc
• IntelGenx Corp.
• Kolon Life Science, Inc.
• Nektar Therapeutics
• Neurocentrx Pharma Ltd.
• Orion Oyj
• Pain Therapeutics, Inc.
• Pfizer Inc.
• Pharmaleads
• PsychoGenics, Inc.
• Recordati S.p.A.
• Ribomic Inc.
• Virobay Inc.
• WEX Pharmaceuticals Inc.
• Winston Pharmaceuticals, Inc.
• Zynerba Pharmaceuticals, Inc.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160205005249/en/

[ Back To TMCnet.com's Homepage ]